Isaac Francis

Ripple has partnered with Project Eleven to strengthen the security of the XRP Ledger against future quantum computing threats.

Polymarket has launched a new category of prediction markets tied to private companies through a partnership with Nasdaq Private Market.

Orezone Gold (ASX:ORE) has delivered a sound performance for the first quarter of 2026, driven by record-high gold prices, tight cost controls, and expanded production.

Japan’s Financial Services Agency has approved rules allowing qualifying foreign trust-type stablecoins to operate within the country’s regulated payment system from June 1, 2026.

Vista Group International (ASX:VGL) secured a landmark six-year agreement with Cinépolis to transition its Mexican circuit to Vista Cloud Operational Excellence.

Cullinan Therapeutics (NYSE:CGEM) received Orphan Drug Designation from the Food and Drug Administration (FDA) for its lead investigational oncology asset, CLN-049, accelerating the regulatory pathway for the treatment of high-risk acute myeloid leukemia (AML).

Sypris Solutions (NASDAQ:SYPR) reported lower first-quarter revenue and a widening net loss, hit by a broader downturn in the commercial vehicle market and persistent component supply shortages that disrupted its electronics manufacturing operations.

BioLineRx (NASDAQ:BLRX) and Hemispherian AS announced encouraging preclinical data for their oncology candidate GLIX1, showcasing the experimental drug’s potential to combat glioblastoma, one of the most aggressive and treatment-resistant forms of brain cancer.

Canaan (NASDAQ:CAN): reported first-quarter revenue in line with its previously issued guidance, anchored by an expansion of its self-mining operations and strategic infrastructure acquisitions despite a challenging environment for hardware sales.

LuxExperience (NYSE:LUXE) reported flat top-line performance on a constant-currency basis for the third quarter of fiscal year 2026, navigating geopolitical headwinds to secure its second consecutive quarter of profitability at the group level.